Trial intelligence / Profile preview

Penthrox for pain reduction during local anaesthetic injection for ingrown toenail surgery

ACTRN12623000936628Phase 4Completed

Sponsor
Claire Huxtable
Start
Nov 2023
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in ingrown nail comparing Penthrox inhaler with Placebo inhaler (2 arms). Primary endpoint: Verbal Numerical Pain Rating Score. Started Nov 2023; status: completed.

02

Drugs

methoxyflurane
03

Conditions

ingrown nail

Beyond the preview

Go deeper on ACTRN12623000936628.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12623000936628.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call